Target Audience

This accredited continuing education activity is designed for nurses, community, and other interested healthcare professionals.

Educational Objectives

At the conclusion of this activity, the participants should be better able to:
• Identify common symptoms of Huntington's Disease
• List pharmacologic treatments for symptoms of Huntington's Disease
• Identify non-pharmacologic management of symptoms of Huntington's Disease

Requirements For Successful Completion

In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.

• Read this front matter information,
• Complete a brief profile on the registration page,
• View the entire webinar recording,
• Complete the post-test and pass with a score of 2 out of 3 or better,
• Complete the online evaluation,
• Click “Claim Certificate”,
• You may now print a copy of your certificate for your records. You may also click on File, Save As, to save the certificate to your PC.

Any questions regarding credit, please contact Courtney Smith 402-559-6618 or courtneyl.smith@unmc.edu

Accreditation

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Olson Center for Women's Health. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.

Disclosure Information

As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
    All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education.  Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
    This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
    All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:

Faculty

• Amy Hellman, MD
  Neurocrine Biosciences: Site-PI Kinect-HD 2

Planning Committee

The below planning committee members have nothing to disclose:

• Heidi Keeler, PhD, RN
• Lana Molczyk, MA
• Renee Paulin, MSN, RN, CWOCN
• Courtney Smith

Financial Support

No commercial support was received for this activity.